Meeting
2022 ASCO Genitourinary Cancers Symposium
Impact of U.S. Preventative Services Task Force grade D recommendation against prostate-specific antigen screening on prostate cancer mortality.
Authors
Laura Burgess
Department of Radiology, Division of Radiation Oncology, University of Ottawa, Ottawa, ON, Canada
Laura Burgess , Christopher M. Aldrighetti , Anushka Ghosh , Andrzej Niemierko , Fumiko Chino , Melissa Jessica Huynh , Jason A. Efstathiou , Sophia C. Kamran
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Quality of Care/Quality Improvement and Real-World Evidence
Citation
J Clin Oncol 40, 2022 (suppl 6; abstr 51)
DOI
10.1200/JCO.2022.40.6_suppl.051
Abstract #
51
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2017 Genitourinary Cancers Symposium
Racial disparities in prostate cancer outcome among prostate-specific antigen screening eligible populations in the United States.
First Author: Brandon Arvin Virgil Mahal
Poster
2015 Genitourinary Cancers Symposium
A community-based approach to educating black men in underserved communities about the risks and benefits of prostate cancer screening.
First Author: Mark Wendell Kennedy
Poster
2024 ASCO Genitourinary Cancers Symposium
Rapid quantification of prostate specific antigen (PSA) from fingerstick (FS) blood.
First Author: Joseph Earl Thomas
Poster
2023 ASCO Annual Meeting
The performance of prostate specific antigen (PSA) testing in the population based NPCC cohort.
First Author: Jan Oldenburg